Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study
ConclusionThe results confirm a safety and effectiveness profile of vedolizumab consistent with that observed in previous trials.Clinical Trial RegistrationJapicCTI-194603, NCT03824561.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Clinical Trials | Drugs & Pharmacology | Herpes | Inflammatory Bowel Disease | Japan Health | Study | Ulcerative Colitis